Amphetamine on Rorschach measures in normal subjects.
Twenty-two normal undergraduate men were administered either d-amphetamine (0.2 mg/kg or 0.4 mg/kg) or placebo in a double-blind, counterbalanced design. The test sessions were exactly three weeks apart and included, among other measures, the Rorschach test. Rorschach anxiety and thought disorder variables were measured under drug and placebo conditions. The results suggest that amphetamine causes an increase in Rorschach anxiety indices but does not elevate Rorschach indices of thought disorder. The observed dissociation of anxiety and thought disorder on the Rorschach has implications for the role of the Rorschach in studying anxiety disorders and schizophrenic disorders.
Perry
W
W
University of California at San Diego, USA.
Sprock
J
J
Schaible
D
D
McDougall
A
A
Minassian
A
A
Jenkins
M
M
Braff
D
D
D000328:Adult; D000661:Amphetamine / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D001007:Anxiety / Q000139:chemically induced; D001794:Blood Pressure / Q000187:drug effects; D004311:Double-Blind Method; D006801:Humans; D008297:Male; D010919:Placebos; D012392:Rorschach Test
D010919:Placebos; D000661:Amphetamine